Altavant Sciences’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Read more

Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Read more

Bill Symonds's photo - CEO of Altavant Sciences

CEO

Bill Symonds

CEO Approval Rating

90/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Breath Therapeutics is Altavant Sciences's #1 competitor. Breath Therapeutics is a Private company that was founded in 2016 in Munich, Bavaria. Breath Therapeutics is in the Biotechnology industry. Compared to Altavant Sciences, Breath Therapeutics has 32 more employees.

Lung Therapeutics is seen as one of Altavant Sciences's biggest rivals. Lung Therapeutics was founded in Austin, Texas} in 2013. Lung Therapeutics is in the Biotechnology field. Compared to Altavant Sciences, Lung Therapeutics generates $8.5M more revenue.

Aqualung Therapeutics is one of Altavant Sciences's top competitors. Aqualung Therapeutics is headquartered in Tucson, Arizona, and was founded in 2010. Aqualung Therapeutics competes in the Biotechnology industry. Aqualung Therapeutics generates 177% the revenue of Altavant Sciences.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $4.5M a good estimate for Altavant Sciences's revenue?

Acquisitions

No recent acquisitions found related to Altavant Sciences

Investments

No recent investments found related to Altavant Sciences

Altavant Sciences News

January 8, 2020The Business Journals: Raleigh/Durham

Cary drugmaker makes first acquisition with new financial backing

A Triangle drugmaker starting the year with a fresh financial backer has made an acquisition of its o... See more »
January 8, 2020The Business Journals: Philadelphia

Wayne biopharmaceutical company sold to North Carolina drug developer

Onspira Therapeutics, a Wayne-based biopharmaceutical company developing treatments for rare pulmonar... See more »
August 5, 2019Drug Development Technology

Altavant doses first patient in ELEVATE 1 trial of PAH drug

Altavant Sciences has dosed the first patient in the ELEVATE 1 trial of its lead candidate rodatrista... See more »
January 3, 2019biocentury

Altavant Sciences subsidiary hired Lyn Baranowski as COO

Altavant Sciences subsidiary hired Lyn Baranowski as COO... See more »

Altavant Sciences Press Releases

August 5, 2019PR Newswire

Altavant Sciences Initiates Phase 2a Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension

CARY, N.C. and BASEL, Switzerland, Aug. 5, 2019 /PRNewswire/ -- Altavant Sciences, a clinical-stage b... See more »
May 9, 2019PR Newswire

Altavant Sciences to Provide Corporate and Clinical Update at 2019 Respiratory Innovation Summit

CARY, N.C. and BASEL, Switzerland, May 9, 2019 /PRNewswire/ -- Altavant Sciences, a company in the Ro... See more »
January 31, 2019PR Newswire

Altavant Sciences to Present Data Supporting Planned Phase 2 Clinical Program for Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension at PVRI World Congress

BASEL, Switzerland and DURHAM, N.C., Jan. 31, 2019 /PRNewswire/ -- Altavant Sciences, a company in th... See more »

Headquarters

6501 Weston Parkway Suite 330

Cary, North Carolina27513

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Altavant Sciences is a biopharmaceutical company that develops and commercializes drug-based therapy for the treatment of respiratory diseases. Altavant Sciences was founded in 2018. Altavant Sciences' headquarters is located in Cary, North Carolina, ...

CEO

Altavant Sciences's CEO, Bill Symonds, currently has an approval rating of 90%. Altavant Sciences's primary competitors are Breath Therapeutics, Lung Therapeutics & Aqualung Therapeutics.

Website

altavant.com

Frequently Asked Questions about Altavant Sciences

  1. When was Altavant Sciences founded?

    Altavant Sciences was founded in 2018
  2. Who is Altavant Sciences's CEO?

    Altavant Sciences's CEO is Bill Symonds
  3. How much revenue does Altavant Sciences generate?

    Altavant Sciences generates $4.5M in revenue
  4. How much funding does Altavant Sciences have?

    Altavant Sciences has historically raised $0 in funding
  1. Where is Altavant Sciences's headquarters?

    Altavant Sciences's headquarters is in Cary North Carolina, USA
  2. How many employees does Altavant Sciences have?

    Altavant Sciences has 25 employees
  3. What sector does Altavant Sciences operate in?

    Altavant Sciences is in Biotechnology, Pharmaceuticals
  4. Who are Altavant Sciences's competitors?

    Altavant Sciences's top competitors are Breath Therapeutics, Lung Therapeutics, Aqualung Therapeutics